Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Knowledge and attitude of hereditary breast cancer among Japanese university female students


BRCA1/2 genetic testing to use PARP inhibitor for breast cancer has a possibility of the “secondary finding” among the younger nonaffected family members of the patient, which turns them into at-risk for hereditary breast cancer. Proper understanding of the background of the hereditary cancer is now required for appropriate acceptance of the risk. Therefore, we investigated the level of knowledge and attitudes of younger women on hereditary breast cancer in Japan. Study subject was Japanese university women between 20 and 30 years of age, without medical history of breast cancer. We conducted the anonymous self-answering questionnaire to them. We received responses from 353 women. The levels of knowledge, awareness, and interest were relatively high. Women with a family history of breast cancer were less likely to undergo testing than women without (92.8% vs. 74.5%, p < 0.001). The rates of positive response toward risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) was significantly high for medical majors compared with that for other majors (RRM: medical 71.6% vs. science 54.5% vs. humanities 53.8%, p = 0.008, RRSO: 35.4% vs. 36.3% vs. 48.4%, p = 0.027). Approximately half of respondents answered that they would hesitate to get married (45.3%) or to have children (55.4%), if they were a BRCA1/2 mutation carrier. The results may help to establish the methods for supporting the decision-making for reproduction of younger women who are unexpectedly labeled as being at-risk for HBOC.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1


  1. 1.

    Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. J Natl Compr Canc Netw. 2017;15:9–20.

    CAS  Article  Google Scholar 

  2. 2.

    Demsky R, McCuaig J, Maganti M, Murphy KJ, Rosen B, Armel SR. Keeping it simple: genetics referrals for all invasive serous ovarian cancers. Gynecol Oncol. 2013;130:329–33.

    CAS  Article  Google Scholar 

  3. 3.

    Morgan D, Sylvester H, Lucas FL, Miesfeldt S. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting. Fam Cancer. 2009;8:277–87.

    CAS  Article  Google Scholar 

  4. 4.

    Forman AD, Hall MJ. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Breast J. 2009;15:S56–62.

    Article  Google Scholar 

  5. 5.

    Terui-Kohbata H, Yotsumoto J, Aoki M, Oishi Y, Uchida N, Akagi K, et al. Barriers to genetic counseling of hereditary breast and ovarian cancer in Japan. Iryo Shakai. 2017;27:261–75.

    Article  Google Scholar 

  6. 6.

    Nakagomi H, Sakamoto I, Hirotsu Y, Amemiya K. Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expenses. Breast Cancer. 2016;23:649–53.

    Article  Google Scholar 

  7. 7.

    Chin TM, Tan SH, Lim SE, Iau P, Yong WP, Wong SW, et al. Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians. Cancer Detect Prev. 2005;29:412–8.

    Article  Google Scholar 

  8. 8.

    Sussner KM, Jandorf L, Thompson HSVH. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City. Psychooncology. 2013;22:1594–604.

    Article  Google Scholar 

  9. 9.

    Anderson B, McLosky J, Wasilevich E, Lyon-Callo S, Duquette D, Copeland G. Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors. J Cancer Epidemiol. 2012;2012:9–11.

    Article  Google Scholar 

  10. 10.

    Mellon S, Gauthier J, Cichon M, Hammad A, Simon MS. Knowledge, attitudes, and beliefs of arab-american women regarding inherited cancer risk. J Genet Couns. 2013;22:268–76.

    Article  Google Scholar 

  11. 11.

    Shirai Y. Idenshi shindan o meguru rinri teki mondai. Byoin. 2001;60:1027–30.

    Google Scholar 

  12. 12.

    Matsumoto T, Morifuji K, Sasaki N, Araki M, Yamasaki M, Miyahara H, et al. Image of genetics. Nagasaki daigaku igakubu hoken gakka kiyo (Bull Nagasaki Univ Sch Heal Sci). 2004;17:17–20.

  13. 13.

    Charles S, Kessler L, Stopfer JE, Domchek S, Halbert CH. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns. 2006;63:196–204.

    Article  Google Scholar 

  14. 14.

    Ando N, Iwamitsu Y, Kuranami M, Okazaki S, Yamamoto K, Watanabe M, et al. Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints. Fam Cancer. 2011;10:681–9.

    Article  Google Scholar 

  15. 15.

    Fortuny D, Balmaña J, Graña B, Torres A, TRY Cajal, Darder E, et al. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Hum Reprod. 2009;24:1000–6.

    Article  Google Scholar 

  16. 16.

    Chan JL, Johnson LNC, Sammel MD, DiGiovanni L, Voong C, Domchek SM, et al. Reproductive decision-making in women with BRCA1/2 mutations. J Genet Couns. 2017;26:594–603.

    Article  Google Scholar 

  17. 17.

    Derks-Smeets IA, Gietel-Habets JJ, Tibben A, Tjan-Heijnen VC, Meijer-Hoogeveen M, Geraedts JP, et al. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Hum Reprod. 2014;29:1103–12.

    CAS  Article  Google Scholar 

  18. 18.

    Gietel-Habets JJ, de Die-Smulders CE, Derks-Smeets IA, Tibben A, Tjan-Heijnen VC, van Golde R, et al. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners. Hum Reprod. 2017;32:588–97.

  19. 19.

    Donnelly LS, Watson M, Moynihan C, Bancroft E, Evans DGR, Eeles R, et al. Reproductive decision-making in young female carriers of a BRCA mutation. Hum Reprod. 2013;28:1006–12.

    CAS  Article  Google Scholar 

  20. 20.

    Gietel-Habets JJG, de Die-Smulders CEM, Derks-Smeets IAP, Tibben A, Tjan-Heijnen VCG, van Golde R, et al. Support needs of couples with hereditary breast and ovarian cancer during reproductive decision making. Psychooncology. 2018;27:1795–801.

    CAS  Article  Google Scholar 

Download references


This survey was supported by Tokyo Interdisciplinary Life Science Consortium. We appreciate Ms Mariko Nakagawa for helping data processing. This research was supported by JSPS KAKENHI Grant number JP17K17689.

Author information



Corresponding author

Correspondence to Masayuki Yoshida.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Terui-Kohbata, H., Egawa, M., Yura, K. et al. Knowledge and attitude of hereditary breast cancer among Japanese university female students. J Hum Genet 65, 591–599 (2020).

Download citation


Quick links